Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects

Inclusion Criteria: * Good general health * Body mass index (BMI) of 18.5-30.0 kg/m\^2 (both inclusive) Exclusion Criteria: * Males who are not willing to use two acceptable forms of highly effective contraception * Participation in another clinical trial within 90 days * Any chronic disorder or severe disease * Use of GLP-1 (glucagon-like peptide-1) agonists within 3 months preceding dosing * Subjects who are smokers * Subjects who have donated any blood or plasma in the past month or in excess of 500 mL within the 12 weeks preceding screening